BNP Paribas Asset Management
CGON icon

BNP Paribas Asset Management’s CG Oncology CGON Stock Holding History

BNP Paribas Asset Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.94M Sell
55,422
-2,310
-4% -$151K ﹤0.01% 960
2026
Q1 		$3.91M Sell
57,732
-386
-0.7% -$21.9K ﹤0.01% 919
2025
Q4 		$2.41M Buy
58,118
+57,737
+15,154% +$2.39M ﹤0.01% 1034
2025
Q3 		$15K Hold
381
– – ﹤0.01% 1487
2025
Q2 		$10K Buy
+381
New +$9.18K ﹤0.01% 1760

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BNP Paribas Asset Management's CGON Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its CG Oncology (CGON) stake by 4% in Q2 2026, selling an estimated $151K and leaving 55,422 shares worth $3.94M. The position accounts for ﹤0.01% of the portfolio, ranked #960.

BNP Paribas Asset Management first reported a position in CGON in Q2 2025 and has held it in 5 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • BNP Paribas Asset Management held 55,422 shares of CG Oncology worth $3.94M as of Q2 2026.
  • BNP Paribas Asset Management sold 2,310 CG Oncology shares in Q2 2026, an estimated $151K.
  • CG Oncology made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #960 holding.
  • BNP Paribas Asset Management first reported a position in CG Oncology in Q2 2025 and has held it in 5 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.